Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa

Adriana Rathner; Petr Rathner; Andreas Friedrich; Michael Wießner; Christian Manuel Kitzler; Jan Schernthaner; Thomas Karl; Jan Krauß; Friedrich Lottspeich; Werner Mewes; Helmut Hintner; Johann W Bauer; Michael Breitenbach; Norbert Müller; Hannelore Breitenbach-Koller; Jörg von Hagen

doi:10.1159/000513260

Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa

Adriana Rathner, Petr Rathner, Andreas Friedrich, Michael Wießner, Christian Manuel Kitzler, Jan Schernthaner, Thomas Karl, Jan Krauß, Friedrich Lottspeich, Werner Mewes, Helmut Hintner, Johann W Bauer, Michael Breitenbach, Norbert Müller, Hannelore Breitenbach-Koller, Jörg von Hagen

Biosciences and Medical Biology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	167-182
Number of pages	16
Journal	Skin Pharmacology and Physiology
Volume	34
Issue number	4
DOIs	https://doi.org/10.1159/000513260
Publication status	Published - 2021

Bibliographical note

Keywords

Artesunate/chemistry
Atazanavir Sulfate/chemistry
Cell Adhesion Molecules/genetics
Epidermolysis Bullosa, Junctional/genetics
Humans
Molecular Docking Simulation
Protein Binding/physiology
RNA, Messenger/metabolism
Ribosomal Proteins/metabolism
Skin/pathology
Skin Physiological Phenomena
Mutations
Epidermolysis bullosa
Drug development
Skin models
Premature termination codon
Ribosomal protein L35
mutations

Fields of Science and Technology Classification 2012

302 Clinical Medicine
304 Medical Biotechnology
106 Biology

Access to Document

10.1159/000513260

Cite this

Rathner, A., Rathner, P., Friedrich, A., Wießner, M., Kitzler, C. M., Schernthaner, J., Karl, T., Krauß, J., Lottspeich, F., Mewes, W., Hintner, H., Bauer, J. W., Breitenbach, M., Müller, N., Breitenbach-Koller, H., & von Hagen, J. (2021). Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa. Skin Pharmacology and Physiology, 34(4), 167-182. https://doi.org/10.1159/000513260

@article{83ed9c0173134e3aad746eef85cfb17c,

title = "Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa",

keywords = "Artesunate/chemistry, Atazanavir Sulfate/chemistry, Cell Adhesion Molecules/genetics, Epidermolysis Bullosa, Junctional/genetics, Humans, Molecular Docking Simulation, Protein Binding/physiology, RNA, Messenger/metabolism, Ribosomal Proteins/metabolism, Skin/pathology, Skin Physiological Phenomena, Mutations, Epidermolysis bullosa, Drug development, Skin models, Premature termination codon, Ribosomal protein L35, mutations",

author = "Adriana Rathner and Petr Rathner and Andreas Friedrich and Michael Wie{\ss}ner and Kitzler, {Christian Manuel} and Jan Schernthaner and Thomas Karl and Jan Krau{\ss} and Friedrich Lottspeich and Werner Mewes and Helmut Hintner and Bauer, {Johann W} and Michael Breitenbach and Norbert M{\"u}ller and Hannelore Breitenbach-Koller and {von Hagen}, J{\"o}rg",

note = "{\textcopyright} 2021 S. Karger AG, Basel.",

year = "2021",

doi = "10.1159/000513260",

language = "English",

volume = "34",

pages = "167--182",

journal = "Skin Pharmacology and Physiology",

issn = "1660-5527",

publisher = "S. Karger AG",

number = "4",

}

Rathner, A, Rathner, P, Friedrich, A, Wießner, M, Kitzler, CM, Schernthaner, J, Karl, T, Krauß, J, Lottspeich, F, Mewes, W, Hintner, H, Bauer, JW, Breitenbach, M, Müller, N, Breitenbach-Koller, H & von Hagen, J 2021, 'Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa', Skin Pharmacology and Physiology, vol. 34, no. 4, pp. 167-182. https://doi.org/10.1159/000513260

TY - JOUR

T1 - Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa

AU - Rathner, Adriana

AU - Rathner, Petr

AU - Friedrich, Andreas

AU - Wießner, Michael

AU - Kitzler, Christian Manuel

AU - Schernthaner, Jan

AU - Karl, Thomas

AU - Krauß, Jan

AU - Lottspeich, Friedrich

AU - Mewes, Werner

AU - Hintner, Helmut

AU - Bauer, Johann W

AU - Breitenbach, Michael

AU - Müller, Norbert

AU - Breitenbach-Koller, Hannelore

AU - von Hagen, Jörg

PY - 2021

Y1 - 2021

KW - Artesunate/chemistry

KW - Atazanavir Sulfate/chemistry

KW - Cell Adhesion Molecules/genetics

KW - Epidermolysis Bullosa, Junctional/genetics

KW - Humans

KW - Molecular Docking Simulation

KW - Protein Binding/physiology

KW - RNA, Messenger/metabolism

KW - Ribosomal Proteins/metabolism

KW - Skin/pathology

KW - Skin Physiological Phenomena

KW - Mutations

KW - Epidermolysis bullosa

KW - Drug development

KW - Skin models

KW - Premature termination codon

KW - Ribosomal protein L35

KW - mutations

UR - http://www.scopus.com/inward/record.url?scp=85103955349&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/376b20fa-fa25-3acd-8f2d-de22a1f3311e/

U2 - 10.1159/000513260

DO - 10.1159/000513260

M3 - Article

C2 - 33823521

SN - 1660-5527

VL - 34

SP - 167

EP - 182

JO - Skin Pharmacology and Physiology

JF - Skin Pharmacology and Physiology

IS - 4

ER -

Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa

Bibliographical note

Keywords

Fields of Science and Technology Classification 2012

Access to Document

Other files and links

Cite this